Radioiodine therapy increases the risk of cerebrovascular events in hyperthyroid and euthyroid patients

European Journal of Endocrinology

Volumn 172, Issue 6, 2015, Pages 771-778

  La Cour, Jeppe Lerche ^a   Jensen, Lars Thorbjoern ^b   Vej Hansen, Anders ^c   Nygaard, Birte ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Region Zealand Hospital Pharmacy   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; ARTICLE; BRAIN ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; HUMAN; HYPERTHYROIDISM; INCIDENCE; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION HAZARD; RADIOTHERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THYROID TUMOR; AGED; CEREBROVASCULAR DISORDERS; DENMARK; FOLLOW UP; GOITER, NODULAR; MIDDLE AGED; REGISTER; RISK; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CEREBROVASCULAR DISORDERS; DENMARK; FEMALE; FOLLOW-UP STUDIES; GOITER, NODULAR; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK;

EID: 84930579060     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-1105     Document Type: Article

References (26)

1. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, Correa C, Cutter D, Gagliardi G, Gigante B et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. New England Journal of Medicine 2013 368 987-998. (doi:10.1056/NEJMoa1209825).
2. la Cour JL, Hedemann-Jensen P, Sogaard-Hansen J, Nygaard B & Jensen LT. Modeling the absorbed dose to the common carotid arteries following radioiodine treatment of benign thyroid disease. Annals of Nuclear Medicine 2013 27 862-866. (doi:10.1007/s12149-013-0756-y).
3. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J & Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. New England Journal of Medicine 1998 338 712-718. (doi:10.1056/NEJM199803123381103).
4. Metso S, Auvinen A, Salmi J, Huhtala H & Jaatinen P. Increased longterm cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clinical Endocrinology 2008 68 450-457. (doi:10.1111/j.1365-2265.2007.03064.x).
5. Stuijver DJ, van Zaane ZB, Romualdi E, Brandjes DP, Gerdes VE & Squizzato A. The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: A systematic review and meta-analysis. Thrombosis and Haemostasis 2012 108 1077-1088. (doi:10.1160/TH12-07-0496).
6. Biondi B & Kahaly GJ. Cardiovascular involvement in patients with different causes of hyperthyroidism. Nature Reviews. Endocrinology 2010 6 431-443. (doi:10.1038/nrendo.2010.105).
7. Sheu JJ, Kang JH, Lin HC & Lin HC. Hyperthyroidism and risk of ischemic stroke in young adults: A 5-year follow-up study. Stroke 2010 41 961-966. (doi:10.1161/STROKEAHA.109.577742).
8. Ryodi E, Salmi J, Jaatinen P, Huhtala H, Saaristo R, Valimaki M, Auvinen A & Metso S. Cardiovascular morbidity and mortality in surgically treated hyperthyroidism - A nation-wide cohort study with a long-term follow-up. Clinical Endocrinology 2014 80 743-750. (doi:10.1111/cen.12359).
9. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study. Lancet 2001 358 861-865. (doi:10.1016/S0140-6736(01)06067-6).
10. Selmer C, Olesen JB, Hansen ML, von Kappelgaard LM, Madsen JC, Hansen PR, Pedersen OD, Faber J, Torp-Pedersen C & Gislason GH. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: A large population study. Journal of Clinical Endocrinology and Metabolism 2014 99 2372-2382. (doi:10.1210/jc.2013-4184).
11. Flynn RW, Macdonald TM, Jung RT, Morris AD & Leese GP. Mortality and vascular outcomes in patients treated for thyroid dysfunction. Journal of Clinical Endocrinology and Metabolism 2006 91 2159-2164. (doi:10.1210/jc.2005-1833).
12. Hoffman DA, McConahey WM, Diamond EL & Kurland LT. Mortality in women treated for hyperthyroidism. American Journal of Epidemiology 1982 115 243-254.
13. Lynge E, Sandegaard JL & Rebolj M. The Danish National Patient Register. Scandinavian Journal of Public Health 2011 39 30-33. (doi:10.1177/1403494811401482).
14. Krarup LH, Boysen G, Janjua H, Prescott E & Truelsen T. Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology 2007 28 150-154. (doi:10.1159/000102143).
15. Jimenez Caballero PE, Lopez EF, Portilla Cuenca JC, RamirezMoreno JM, Pedrera Zamorano JD & Casado NI. Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor ofmortality and functional outcome after 6 months. Journal of Stroke and Cerebrovascular Diseases 2013 22 e214-e218. (doi:10.1016/j.jstrokecerebrovasdis. 2012.11.014).
16. Thygesen SK, Christiansen CF, Christensen S, Lash TL & Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Medical Research Methodology 2011 11 83. (doi:10.1186/1471-2288-11-83).
17. Stewart FA. Mechanisms and dose-response relationships for radiationinduced cardiovascular disease. Annals of the ICRP 2012 41 72-79. (doi:10.1016/j.icrp.2012.06.031).
18. Surucu E, Bekis R, Sengoz T, Demir Y, Celik AO, Orbay O, Birlik B, Ozdogan O, Igci E & Durak H. The effect of radioiodine on the intima media thickness of the carotid artery. Molecular Imaging and Radionuclide Therapy 2013 22 85-89. (doi:10.4274/Mirt.24119).
19. van den Oord SC, Sijbrands EJ, ten Kate GL, van Klaveren D, van Domburg RT, van der Steen AF & Schinkel AF. Carotid intima-media thickness for cardiovascular risk assessment: Systematic review and meta-analysis. Atherosclerosis 2013 228 1-11. (doi:10.1016/j.atherosclerosis. 2013.01.025).
20. Volzke H, Robinson DM, Schminke U, Ludemann J, Rettig R, Felix SB, Kessler C, John U & Meng W. Thyroid function and carotid wall thickness. Journal of Clinical Endocrinology and Metabolism 2004 89 2145-2149. (doi:10.1210/jc.2003-031028).
21. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H & Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 2007 92 2190-2196. (doi:10.1210/jc.2006-2321).
22. Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, Faber J, Hansen PR, Pedersen OD, Torp-Pedersen C et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: A large population cohort study. BMJ 2012 345 e7895. (doi:10.1136/bmj.e7895).
23. Dorr M, Empen K, Robinson DM, Wallaschofski H, Felix SB & Volzke H. The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodinedeficient area. European Journal of Endocrinology 2008 159 145-152. (doi:10.1530/EJE-08-0140).
24. Chaker L, Baumgartner C, Ikram MA, Dehghan A, MediciM, Visser WE, Hofman A, Rodondi N, Peeters RP & Franco OH. Subclinical thyroid dysfunction and the risk of stroke: A systematic review and metaanalysis. European Journal of Epidemiology 2014 29 791-800. (doi:10.1007/s10654-014-9946-8).
25. Boelaert K, Maisonneuve P, Torlinska B & Franklyn JA. Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine. Journal of Clinical Endocrinology and Metabolism 2013 98 1869-1882. (doi:10.1210/jc.2012-3459).
26. Knudsen N, Bulow I, Laurberg P, Ovesen L, Perrild H& Jorgensen T. Low socio-economic status and familial occurrence of goitre are associated with a high prevalence of goitre. European Journal of Epidemiology 2003 18 175-181. (doi:10.1023/A:1023001400945).